- Home
- PRAX vs GDEN Comparison
PRAX vs GDEN Comparison
Compare PRAX & GDEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- GDEN
- Stock Information
- Founded
- PRAX 2015
- GDEN 1998
- Country
- PRAX United States
- GDEN United States
- Employees
- PRAX N/A
- GDEN N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- GDEN Services-Misc. Amusement & Recreation
- Sector
- PRAX Health Care
- GDEN Consumer Discretionary
- Exchange
- PRAX Nasdaq
- GDEN Nasdaq
- Market Cap
- PRAX 1.2B
- GDEN 961.7M
- IPO Year
- PRAX 2020
- GDEN 1999
- Fundamental
- Price
- PRAX $71.76
- GDEN $33.19
- Analyst Decision
- PRAX Strong Buy
- GDEN Strong Buy
- Analyst Count
- PRAX 9
- GDEN 5
- Target Price
- PRAX $146.33
- GDEN $37.00
- AVG Volume (30 Days)
- PRAX 317.5K
- GDEN 221.1K
- Earning Date
- PRAX 11-06-2024
- GDEN 11-07-2024
- Dividend Yield
- PRAX N/A
- GDEN 3.01%
- EPS Growth
- PRAX N/A
- GDEN N/A
- EPS
- PRAX N/A
- GDEN 1.27
- Revenue
- PRAX $1,605,000.00
- GDEN $733,305,000.00
- Revenue This Year
- PRAX N/A
- GDEN N/A
- Revenue Next Year
- PRAX N/A
- GDEN $2.27
- P/E Ratio
- PRAX N/A
- GDEN $26.19
- Revenue Growth
- PRAX N/A
- GDEN N/A
- 52 Week Low
- PRAX $14.25
- GDEN $27.42
- 52 Week High
- PRAX $86.93
- GDEN $42.14
- Technical
- Relative Strength Index (RSI)
- PRAX 48.78
- GDEN 62.87
- Support Level
- PRAX $58.84
- GDEN $30.26
- Resistance Level
- PRAX $86.93
- GDEN $34.56
- Average True Range (ATR)
- PRAX 6.09
- GDEN 1.12
- MACD
- PRAX -0.15
- GDEN 0.41
- Stochastic Oscillator
- PRAX 46.00
- GDEN 77.94
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.